Psychiatric Multi-omics and Neuroimaging Project
This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.
Conditions studied
Mental Disorders, Healthy Control
About this study
This study focuses on the structure and function of the brain and gene expression in peripheral blood of patients with schizophrenia, to explore the interaction and influence between the three. Patients with mental disorders who have been recruited will take their medication regularly for 1 year and participate in baseline and follow-up assessments.
Interventions
- Drug: Antipsychotic drugs, antidepressants, mood stabilizers, and sleep aids — Patients with mental disorders should take the appropriate medicine as prescribed by the doctor,and the health norms are not required to take medicine.This study will not interfere with the medication regimen of doctors.
Primary outcomes
- cortical morphology (40 minutes)
- target gene charaacteristics (1 day)
- scale scores (90 minutes.)
Eligibility information
Study locations
- The Second Xiangya hospital of central south univerity, Changsha, Hunan 410000 China
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.